The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study has suggested.
The research, published in the scientific journal Nature Medicine, found that participants who used the class of drugs which includes Wegovy and Ozempic had a lower risk of 42 health conditions compared with those who took other diabetes medications.
The conditions included heart and blood disorders such as deep vein thrombosis and heart attack, as well as neurocognitive disorders including Alzheimer’s disease and dementia.
The study, based on analysis of data from 2.4 million participants, also suggested potential beneficial effects beyond those currently recognised, including a lower risk of substance use disorders, psychotic disorders, seizures, bacterial infections and…